Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Pharm-Bio Serv Inc
(OP:
PBSV
)
0.4800
UNCHANGED
Last Price
Updated: 10:10 AM EDT, Mar 10, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Pharm-Bio Serv Inc
Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2026
March 17, 2026
Via
ACCESS Newswire
Pharma-Bio Serv Announces Full Year Results and Special Dividend
January 29, 2026
Via
ACCESS Newswire
Pharma-Bio Serv Announces Results for the Quarter Ended July 31, 2025
September 15, 2025
Via
ACCESS Newswire
Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2025
June 16, 2025
Via
ACCESS Newswire
Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2025
March 17, 2025
Via
ACCESS Newswire
Pharma-Bio Serv Announces Full Year Results
January 29, 2025
Via
ACCESS Newswire
Pharma-Bio Serv Announces Special Dividend
January 29, 2025
Via
ACCESS Newswire
Pharma-Bio Serv Announces Results for the Quarter Ended July 31, 2024
September 16, 2024
Via
ACCESSWIRE
Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2024
June 14, 2024
Via
ACCESSWIRE
Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2024
March 18, 2024
Via
ACCESSWIRE
Pharma-Bio Serv Announces Full Year Results
January 29, 2024
Via
ACCESSWIRE
Pharma-Bio Serv Announces Special Dividend
December 21, 2023
Via
ACCESSWIRE
Pharma-Bio Serv Announces Results for the Three and Nine Months Ended July 31, 2023
September 14, 2023
Via
ACCESSWIRE
Pharma-Bio Serv Announces Results for the Three and Six Months Ended April 30, 2023
June 14, 2023
Via
ACCESSWIRE
Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2023
March 17, 2023
Via
ACCESSWIRE
Pharma-Bio Serv Announces Special Dividend
March 01, 2023
Via
ACCESSWIRE
Pharma-Bio Serv Retains Investment Banking Firm ACP Capital to Provide Investment Banking and M&A Advisory Services
February 07, 2023
Via
ACCESSWIRE
Pharma-Bio Serv Announces Full Year Results
January 30, 2023
Via
ACCESSWIRE
Pharma-Bio Serv Announces Results for the Three and Nine Months Ended July 31, 2022
September 14, 2022
Via
ACCESSWIRE
Pharma-Bio Serv Announces Results for the Three and Six Months Ended April 30, 2022
June 14, 2022
DORADO, PUERTO RICO / ACCESSWIRE / June 14, 2022 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting...
From
Pharma-Bio Serv Inc.
Via
AccessWire
Topics
Economy
Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2022
March 17, 2022
DORADO, PUERTO RICO / ACCESSWIRE / March 17, 2022 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting...
From
Pharma-Bio Serv Inc.
Via
AccessWire
Pharma-Bio Serv Announces Full Year Results and Declares a Special Dividend
February 11, 2022
DORADO, PUERTO RICO / ACCESSWIRE / February 11, 2022 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a regulatory, compliance, project management and technology transfer...
From
Pharma-Bio Serv Inc.
Via
AccessWire
Pharma-Bio Serv Announces Special Dividend
November 15, 2021
DORADO, PUERTO RICO / ACCESSWIRE / November 15, 2021 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a regulatory, compliance, project management and technology transfer...
From
Pharma-Bio Serv Inc.
Via
AccessWire
Pharma-Bio Serv Announces Results for the Quarter Ended July 31, 2021
September 14, 2021
DORADO, PUERTO RICO / ACCESSWIRE / September 14, 2021 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a regulatory, compliance, project management and technology transfer...
From
Pharma-Bio Serv Inc.
Via
AccessWire
Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2021
June 14, 2021
Announces Regulatory and Compliance Advisory Board DORADO, PUERTO RICO / ACCESSWIRE / June 14, 2021 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project...
From
Pharma-Bio Serv Inc.
Via
AccessWire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
